Market Overview:
The global tumor radiofrequency ablation market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, technological advancements in tumor RF ablation devices, and rising demand for minimally invasive procedures. Based on type, the global tumor RF ablation market is segmented into lung cancer, kidney cancer, breast cancer, prostate cancer, liver cancer and others. Lung Cancer is estimated to account for the largest share of the global tumor RF ablation market in 2018 owing to its high incidence rate across the globe. Based on application hospitals are estimated account for majority share of revenue generated by this market followed by Cancer Specialty Clinics during forecast period (2018-2030).
Product Definition:
A tumor is a mass or lump that, although not always cancerous, can be a sign of cancer. A tumor radiofrequency ablation (TRA) is a nonsurgical treatment for tumors. It uses heat to destroy the tumor cells. This treatment is used to treat small tumors and those that are difficult to remove surgically.
Lung Cancer:
Lung cancer is a type of cancer that begins in the lung tissues and bronchus. The most common types of lung cancers are non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC). NSCLCs accounts for the majority of cases globally, while SCLCs are more prevalent in North America.
Kidney Cancer:
The kidney cancer is also known as renal cell carcinoma. It is a form of cancer that develops from the cells of the kidney. The most common symptoms include blood in urine, frequent urination, and swelling in lower abdomen. If not treated at an early stage then it may spread to other organs such as liver and lungs leading to death of the patient usually within 3-5 years.
Application Insights:
The others segment held the largest share of more than 60.0% in 2017. This is due to the high usage rate of radiofrequency ablation for liver cancer, breast cancer, prostate cancer and kidney cancer treatment in non-hospital settings. In addition, a rise in RFA procedures for lung and pancreatic cancers has also positively influenced segment growth during the forecast period.
Hospitals are expected to be one of the fastest growing segments over the forecast period owing to increasing adoption rate of advanced technologies such as HDR and LDR techniques coupled with technological advancements made by market players such as RF Generator Corporation and Livent Inc., respectively (both based in Canada). Furthermore, hospitals have been adopting a proactive approach towards patient education which includes providing information regarding tumor location along with risk factors associated with different types of tumors leading up to treatment at hospital level.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of centers and institutes offering radiofrequency ablation procedures, availability of technologically advanced devices, high healthcare expenditure, and rising incidence rates of cancer. According to the American Cancer Society (ACS), Inc., in 2018 there will be an estimated 1.7 million new cases diagnosed in men and women throughout North America.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for tumor radiofrequency ablation market. According to World Health Organization (WHO), the number of new cases diagnosed with cancer every year is estimated to be around 14 million and it is expected to rise by 70% in next two decades. This will create a huge demand for tumor radiofrequency ablation devices and services, which will drive the growth of tumor radiofrequency ablation market.
- Rising awareness about benefits of tumor radiofrequency ablation: There is a growing awareness among people about benefits of tumor radiofrequency ablation over traditional treatments such as surgery and chemotherapy. This has led to an increase in adoption rate of tumor radiosurgery procedures across the globe, which in turn is propelling the growth of global Tumor Radiofrequency Ablation market.
- Technological advancements: The technological advancements in field off medical devices are helping fuel the growth prospects for Tumor Radio frequency Ablation market players globally as they are introducing innovative products that offer better treatment outcomes at lower costs than traditional treatments options available currently.. For instance, In November 2017, Hologic Corporation announced launch its newest Selenia Dimensions 3D mammography system that offers superior image quality with low dose radiation exposure levels compared to other systems available in market currently . Such technological advancements are aiding wider adoption ratesofTumorRadio frequencyAblationdevicesandhelpingtogrowtheglobalmarket sizeforTum
Scope Of The Report
Report Attributes
Report Details
Report Title
Tumor Radiofrequency Ablation Market Research Report
By Type
Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Others
By Application
Hospitals, Cancer Specialty Clinics, Others
By Companies
Boston Scientific, Diros Technology, Halyard Health, St. Jude Medical, Cosman Medical, Medtronic, NeuroTherm, Stryker, Cosman Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Tumor Radiofrequency Ablation Market Report Segments:
The global Tumor Radiofrequency Ablation market is segmented on the basis of:
Types
Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Cancer Specialty Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Diros Technology
- Halyard Health
- St. Jude Medical
- Cosman Medical
- Medtronic
- NeuroTherm
- Stryker
- Cosman Medical
Highlights of The Tumor Radiofrequency Ablation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lung Cancer
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Others
- By Application:
- Hospitals
- Cancer Specialty Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tumor Radiofrequency Ablation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tumor radiofrequency ablation (TRA) is a minimally invasive procedure that uses heat and radio waves to destroy cancer cells. The goal of TRA is to reduce the size or remove the tumor.
Some of the major players in the tumor radiofrequency ablation market are Boston Scientific, Diros Technology, Halyard Health, St. Jude Medical, Cosman Medical, Medtronic, NeuroTherm, Stryker, Cosman Medical.
The tumor radiofrequency ablation market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tumor Radiofrequency Ablation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tumor Radiofrequency Ablation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tumor Radiofrequency Ablation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tumor Radiofrequency Ablation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tumor Radiofrequency Ablation Market Size & Forecast, 2018-2028
4.5.1 Tumor Radiofrequency Ablation Market Size and Y-o-Y Growth
4.5.2 Tumor Radiofrequency Ablation Market Absolute $ Opportunity
Chapter 5 Global Tumor Radiofrequency Ablation Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tumor Radiofrequency Ablation Market Size Forecast by Type
5.2.1 Lung Cancer
5.2.2 Kidney Cancer
5.2.3 Breast Cancer
5.2.4 Prostate Cancer
5.2.5 Liver Cancer
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tumor Radiofrequency Ablation Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tumor Radiofrequency Ablation Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Cancer Specialty Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tumor Radiofrequency Ablation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tumor Radiofrequency Ablation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tumor Radiofrequency Ablation Analysis and Forecast
9.1 Introduction
9.2 North America Tumor Radiofrequency Ablation Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tumor Radiofrequency Ablation Market Size Forecast by Type
9.6.1 Lung Cancer
9.6.2 Kidney Cancer
9.6.3 Breast Cancer
9.6.4 Prostate Cancer
9.6.5 Liver Cancer
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tumor Radiofrequency Ablation Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Cancer Specialty Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tumor Radiofrequency Ablation Analysis and Forecast
10.1 Introduction
10.2 Europe Tumor Radiofrequency Ablation Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tumor Radiofrequency Ablation Market Size Forecast by Type
10.6.1 Lung Cancer
10.6.2 Kidney Cancer
10.6.3 Breast Cancer
10.6.4 Prostate Cancer
10.6.5 Liver Cancer
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tumor Radiofrequency Ablation Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Cancer Specialty Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tumor Radiofrequency Ablation Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tumor Radiofrequency Ablation Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tumor Radiofrequency Ablation Market Size Forecast by Type
11.6.1 Lung Cancer
11.6.2 Kidney Cancer
11.6.3 Breast Cancer
11.6.4 Prostate Cancer
11.6.5 Liver Cancer
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tumor Radiofrequency Ablation Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Cancer Specialty Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tumor Radiofrequency Ablation Analysis and Forecast
12.1 Introduction
12.2 Latin America Tumor Radiofrequency Ablation Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tumor Radiofrequency Ablation Market Size Forecast by Type
12.6.1 Lung Cancer
12.6.2 Kidney Cancer
12.6.3 Breast Cancer
12.6.4 Prostate Cancer
12.6.5 Liver Cancer
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tumor Radiofrequency Ablation Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Cancer Specialty Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tumor Radiofrequency Ablation Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tumor Radiofrequency Ablation Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tumor Radiofrequency Ablation Market Size Forecast by Type
13.6.1 Lung Cancer
13.6.2 Kidney Cancer
13.6.3 Breast Cancer
13.6.4 Prostate Cancer
13.6.5 Liver Cancer
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tumor Radiofrequency Ablation Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Cancer Specialty Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tumor Radiofrequency Ablation Market: Competitive Dashboard
14.2 Global Tumor Radiofrequency Ablation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Diros Technology
14.3.3 Halyard Health
14.3.4 St. Jude Medical
14.3.5 Cosman Medical
14.3.6 Medtronic
14.3.7 NeuroTherm
14.3.8 Stryker
14.3.9 Cosman Medical
